CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13,000 enrolled
Drug / intervention
historyother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03831490
NCT03831490N/ACompleted

IMPACT - Study for Improving Maternal, Pregnancy and Child Outcomes

Uppsala University·observational·Posted Feb 5, 2019·Updated May 9, 2024

In Brief

An observational study evaluating history for Pre-Eclampsia. Completed, enrolled 13,000 participants across 9 sites.

Detailed Summary

The overall aims of this proposal are to improve, facilitate, optimize and equalize the existing screening system for adverse pregnancy outcomes in early pregnancy in order to limit adverse consequences for both the mother and infant, by: 1. Creating a Swedish prediction model with population-specific risk factors, optimized for the Swedish health care system, identifying high-risk women for preterm preeclampsia and validate the model within the cohort. This would give us the possibility to start aspirin prophylaxis in time, which has been proven to reduce the risk of developing preterm preeclampsia by 50%. 2. Validating the Fetal Medicine Foundation prediction model for detection of preterm (\< 37 gestational weeks) preeclampsia in a Swedish population. 3. Creating a prediction model identifying high-risk women for overall preeclampsia during pregnancy and birth of a small for gestational age infant in order to plan individualized surveillance for early detection, which has been proven beneficial for both the mother and infant. 4. Creating a national pregnancy biobank with blood samples and individual clinical registry data, including pregnancy outcomes, enabling future research on prevention and early detection for various adverse pregnancy outcomes which could be such as preterm birth and intrauterine growth restriction.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPre-Eclampsia
CountriesSweden

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedFeb 5, 2019
Enrollment StartNov 9, 2018
Primary CompletionDec 31, 2022
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 7.4 years ago

Interventions

historyother

combining these 4 interventions will great an algorithm predicting preeclampsia